For research use only. Not for therapeutic Use.
ACY-775 (Cat.No:I001156) is a potent and selective HDAC6 inhbiitor. ACY-775 inhibits HDAC6 with low nanomolar potency and a selectivity of 60- to 1500-fold over class I HDACs. ACY-775 shares the antidepressant-like properties of other HDAC inhibitors, such as SAHA and MS-275, in the tail suspension test and social defeat paradigm.
| Catalog Number | I001156 |
| CAS Number | 1375466-18-4 |
| Synonyms | ACY-775; ACY 775; ACY775.;2-((1-(3-Fluorophenyl)cyclohexyl)amino)-N-hydroxypyrimidine-5-carboxamide |
| Molecular Formula | C17H19FN4O2 |
| Purity | ≥95% |
| Target | Epigenetics |
| Solubility | Soluble in DMSO, not in water |
| Storage | 0 - 4°Cfor short term (days to weeks), or -20 °C for long term (months). |
| IUPAC Name | 2-[[1-(3-fluorophenyl)cyclohexyl]amino]-N-hydroxypyrimidine-5-carboxamide |
| InChI | InChI=1S/C17H19FN4O2/c18-14-6-4-5-13(9-14)17(7-2-1-3-8-17)21-16-19-10-12(11-20-16)15(23)22-24/h4-6,9-11,24H,1-3,7-8H2,(H,22,23)(H,19,20,21) |
| InChIKey | IYBURCQQEUNLDL-UHFFFAOYSA-N |
| SMILES | O=C(C1=CN=C(NC2(C3=CC=CC(F)=C3)CCCCC2)N=C1)NO |
| Reference | </br>1: Jochems J, Boulden J, Lee BG, Blendy JA, Jarpe M, Mazitschek R, Van Duzer JH, </br> Jones S, Berton O. Antidepressant-like properties of novel HDAC6-selective</br> inhibitors with improved brain bioavailability. Neuropsychopharmacology. 2014</br> Jan;39(2):389-400. doi: 10.1038/npp.2013.207. Epub 2013 Aug 19. PubMed PMID:</br> 23954848; PubMed Central PMCID: PMC3870780.</br>2: Mithraprabhu S, Khong T, Jones SS, Spencer A. Histone deacetylase (HDAC)</br> inhibitors as single agents induce multiple myeloma cell death principally</br> through the inhibition of class I HDAC. Br J Haematol. 2013 Aug;162(4):559-62.</br> doi: 10.1111/bjh.12388. Epub 2013 May 21. PubMed PMID: 23692150.</br></br> |
